| 1.86 0 (0%) | 04-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.89 | 1-year : | 3.39 |
| Resists | First : | 2.47 | Second : | 2.91 |
| Pivot price | 1.94  |
|||
| Supports | First : | 1.77 | Second : | 1.48 |
| MAs | MA(5) : | 1.89 |
MA(20) : | 1.98 |
| MA(100) : | 1.82 |
MA(250) : | 1.62 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 19.1 |
D(3) : | 22.4 |
| RSI | RSI(14): 41.7 | |||
| 52-week | High : | 2.91 | Low : | 0.97 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ OGI ] has closed above bottom band by 28.7%. Bollinger Bands are 26.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.94 - 1.95 | 1.95 - 1.96 |
| Low: | 1.83 - 1.84 | 1.84 - 1.85 |
| Close: | 1.84 - 1.86 | 1.86 - 1.88 |
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Fri, 26 Apr 2024
Are Medical Stocks Lagging OrganiGram (OGI) This Year? - Yahoo Finance
Sun, 21 Apr 2024
Organigram Is My Favorite Cannabis Stock Again (NASDAQ:OGI) - Seeking Alpha
Sat, 20 Apr 2024
Organigram Stock: Operating In A Structurally Challenged Industry (NASDAQ:OGI) - Seeking Alpha
Tue, 02 Apr 2024
Organigram Bolsters Finances with Successful Offering - TipRanks.com - TipRanks
Mon, 01 Apr 2024
Is it Time to Dump OrganiGram Holdings Inc (OGI) Stock After it Is Lower By 23.90% in a Week? - InvestorsObserver
Wed, 27 Mar 2024
Organigram Announces Pricing of Overnight Marketed Public Offering - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 103 (M) |
| Shares Float | 68 (M) |
| Held by Insiders | 27.3 (%) |
| Held by Institutions | 8.8 (%) |
| Shares Short | 3,570 (K) |
| Shares Short P.Month | 3,560 (K) |
| EPS | -1.83 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.18 |
| Profit Margin | -153.9 % |
| Operating Margin | -43.7 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.44 |
| EBITDA (p.s.) | -0.25 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -36 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -1.03 |
| PEG Ratio | 0 |
| Price to Book value | 0.58 |
| Price to Sales | 1.28 |
| Price to Cash Flow | -5.36 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|